Publications
Found 2 results
Filters: Author is B.D.B. Souza [Clear All Filters]
, “Persistent glucocorticoid resistance in systemic lupus erythematosus patients during clinical remission”, vol. 12, pp. 2010-2019, 2013.
, “Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients”, vol. 9, pp. 2300-2310, 2010.
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). Guidelines for the management of rheumatoid arthritis. Arthitis Rheum. 46: 328-346.
http://dx.doi.org/10.1002/art.10148
PMid:11840435
Asahara H, Fujisawa K, Kobata T, Hasunuma T, et al. (1997). Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40: 912-918.
http://dx.doi.org/10.1002/art.1780400520
PMid:9153554
Baeuerle PA and Baltimore D (1996). NF-kappa B: ten years after. Cell 87: 13-20.
http://dx.doi.org/10.1016/S0092-8674(00)81318-5
Baldwin AS Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
http://dx.doi.org/10.1146/annurev.immunol.14.1.649
PMid:8717528
Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, et al. (2007). Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatóide. Rev. Bras. Reumatol. 47: 151-159.
Boss B and Neeck G (2000). Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z. Rheumatol. (Suppl 2) 59: II-62-II-64.
http://dx.doi.org/10.1007/s003930070020
Brenol CV, Monticielo OA, Xavier RM and Brenol JCT (2007). Artrite reumatóide e aterosclerose. Rev. Assoc. Med. Bras. 53: 465-470.
http://dx.doi.org/10.1590/S0104-42302007000500026
PMid:17952359
Callahan LF, Pincus T, Huston JW III, Brooks RH, et al. (1997). Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res. 10: 381-394.
http://dx.doi.org/10.1002/art.1790100606
PMid:9481230
Carlsson AM (1983). Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16: 87-101.
http://dx.doi.org/10.1016/0304-3959(83)90088-X
Cobra JF, Melo MR, Faria CD, Longui CA, et al. (2009). Simultaneous evaluation of in vivo glucocorticoid sensitivity and expression of glucocorticoid receptor alpha-isoform in rheumatoid arthritis patients. Arq. Bras. Endocrinol. Metabol. 53: 24-30.
http://dx.doi.org/10.1590/S0004-27302009000100005
PMid:19347182
Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, et al. (1997). Circadian relationships between interleukin (IL)- 6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283.
http://dx.doi.org/10.1210/jc.82.4.1279
PMid:9100607
De Bosscher K, Vanden Berghe W and Haegeman G (2001). Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15: 219-227.
http://dx.doi.org/10.1210/me.15.2.219
PMid:11158329
Eggert M, Schulz M and Neeck G (2001). Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J. Steroid Biochem. Mol. Biol. 77: 185-191.
http://dx.doi.org/10.1016/S0960-0760(01)00058-9
Eggert M, Kluter A, Rusch D, Schmidt KL, et al. (2002). Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J. Rheumatol. 29: 2500-2506.
PMid:12465142
Faria CD, Cobra JF, Sousa E Silva, Melo MR, et al. (2008). A very low dose intravenous dexamethasone suppression test as an index of glucocorticoid sensitivity. Horm. Res. 69: 357-362.
http://dx.doi.org/10.1159/000117392
PMid:18504395
Faria CDC, Castro RB, Longui CA, Kochi C, et al. (2010). Impact of prolonged low-grade physical training on the in vivo glucocorticoid sensitivity and on glucocorticoid receptor mRNA levels of obese adolescents. Horm. Res. Paediatr. 73: 458-464.
http://dx.doi.org/10.1159/000313591
PMid:20407233
Firestein GS (2004). NF-kappaB: Holy Grail for rheumatoid arthritis? Arthritis Rheum. 50: 2381-2386.
http://dx.doi.org/10.1002/art.20468
PMid:15334448
Fries JF, Spitz PW and Young DY (1982). The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J. Rheumatol. 9: 789-793.
PMid:7175852
Fujisawa K, Aono H, Hasunuma T, Yamamoto K, et al. (1996). Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 39: 197-203.
http://dx.doi.org/10.1002/art.1780390205
PMid:8849369
Ghosh S, May MJ and Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
http://dx.doi.org/10.1146/annurev.immunol.16.1.225
PMid:9597130
Longui CA and Faria CD (2009). Evaluation of glucocorticoid sensitivity and its potential clinical applicability. Horm. Res. 71: 305-309.
http://dx.doi.org/10.1159/000223413
PMid:19506386
Louzada-Junior P, Souza BDB, Toledo RA and Ciconelli RM (2007). Análise descritiva das características demográficas e clínicas de pacientes com artrite reumatóide no estado de São Paulo, Brasil. Rev. Bras. Reumatol. 47: 84-90.
http://dx.doi.org/10.1590/S0482-50042007000200002
McKay LI and Cidlowski JA (1999). Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20: 435-459.
http://dx.doi.org/10.1210/er.20.4.435
PMid:10453354